P. Boulet

发表

Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?

P. Ghys, E. Beck, S. Mandalia, 2019, Global health action.

Essential drugs in the new international economic environment.

G. Velásquez, P. Boulet, 1999, Bulletin of the World Health Organization.

Patent situation of HIV / AIDS-related drugs in 80 countries.

J. Perriens, P. Boulet, F. Renaud-Théry, 2000 .

A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology

Brook K. Baker, M. Torrent, Viviana MuÑoz Tellez, 2022, BMJ Global Health.

Scaling-Up Vaccine Production Capacity: Legal Challenges and Recommendations

P. Boulet, E. Hoen, C. Garrison, 2021 .

Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation

Brook K. Baker, P. Boulet, E. '. ‘t Hoen, 2017, Journal of Pharmaceutical Policy and Practice.

Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib

G. Krikorian, P. Boulet, Yuanqiong Hu, 2020, Journal of pharmaceutical policy and practice.

Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib

G. Krikorian, P. Boulet, Yuanqiong Hu, 2020, Journal of Pharmaceutical Policy and Practice.

Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too

P. Boulet, K. Perehudoff, E. '. ‘t Hoen, 2021, BMJ Global Health.

Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation

Brook K. Baker, P. Boulet, E. '. ‘t Hoen, 2017, Journal of pharmaceutical policy and practice.

Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors

David D. L. Minh, Vincent A. Voelz, Matthew F. D. Hurley, 2023, bioRxiv.

Registering New Drugs for Low-Income Countries: The African Challenge

Nathalie Strub-Wourgaft, B. Pécoul, P. Boulet, 2011, PLoS medicine.

Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.

P. Boulet, Tapiwanashe Kujinga, E. '. ‘t Hoen, 2018, Journal of pharmaceutical policy and practice.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

R. Peeling, J. Ward, Rakesh Aggarwal, 2019, The lancet. Gastroenterology & hepatology.

Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.

P. Boulet, Tapiwanashe Kujinga, E. '. ‘t Hoen, 2018, Journal of Pharmaceutical Policy and Practice.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

R. Peeling, Rakesh Aggarwal, S. Taylor-Robinson, 2019, The lancet. Gastroenterology & hepatology.